Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 54 clinical trials
Featured trial
Pneumococcal Infection

prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal disease

pneumococcal
polysaccharide
conjugate vaccine
covid-19
  • 0 views
  • 13 Jan, 2022
  • 1 location
Featured trial
Pneumococcal Infection

prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal disease

polysaccharide
covid-19
  • 0 views
  • 18 Apr, 2022
  • 1 location
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

administered concomitantly with Pneumococcal conjugate vaccine (PCV 13) and other recommended routine infant vaccines(RIV).

vaccination
varivax
conjugate vaccine
pneumococcal
Accepts healthy volunteers
  • 268 views
  • 12 May, 2022
  • 30 locations
Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations

The pandemic caused by the novel coronavirus SARS-CoV-2 has resulted in substantial global morbidity and mortality including in Oklahoma and caused unprecedented interruptions in nearly all aspects of our lives. The population of the state of Oklahoma is at particular risk to SARS-CoV-2 due to its large rural population, strained …

  • 0 views
  • 14 May, 2021
  • 1 location
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

, embolization, or removal of the spleen. The purpose of this study is to investigate the antibody response to pneumococcal vaccine in patients undergoing these modes of therapy.

  • 1 views
  • 23 Mar, 2022
  • 1 location
Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients. (SPLENEVAC-2)

This research is a multi-center French randomized and double blind phase IIb clinical trial evaluating 2 revaccination strategies against pneumococcal infections among splenectomised patients

  • 0 views
  • 01 Mar, 2022
Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens

The investigators seek to conduct a prospective, longitudinal study to identify the dynamic changes in nasopharyngeal (NP) colonization patterns and acute otitis media (AOM) etiology involving antibiotic-resistant Streptococcus pneumoniae (Spn) and Haemophilus influenzae (Hflu).

  • 0 views
  • 23 Jul, 2021
  • 1 location
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults

The objective of the study is to evaluate the safety and tolerability of a single injection of VAX-24 at 3 dose levels compared to Prevnar 20™ (PCV20) in adults 18 to 49 years of age in Phase 1. The Phase 2 will evaluate the safety, tolerability, and immunogenicity of a …

Accepts healthy volunteers
  • 0 views
  • 06 May, 2022
  • 8 locations
Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)

prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal disease

conjugate vaccine
v110
booster
pneumococcal conjugate
Accepts healthy volunteers
  • 0 views
  • 01 May, 2022
  • 42 locations
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 (QIV;PPV23)

The main objective of this study was to evaluate the immunogenicity and safety of the booster dose of COVID-19 inactivated vaccine and co-immunization with quadrivalent influenza vaccine and 23-valent pneumonia polysaccharide vaccine in people aged 18 years and older. A randomized controlled, open trial design was adopted. The study was …

booster
Accepts healthy volunteers
inactivated vaccine
trivalent influenza vaccine
quadrivalent inactivated influenza vaccine
  • 0 views
  • 11 Apr, 2022